YORK, Aug. 5, 2022 /PRNewswire/ -- Jakubowitz
Law announces that a securities fraud class action lawsuit has
commenced on behalf of shareholders of Apyx Medical Corporation
To receive updates on the lawsuit, fill out the
The lawsuit seeks to recover losses for shareholders who
purchased Apyx between May 12, 2021
and March 11, 2022.
Shareholders interested in acting as a lead plaintiff
representing the class of wronged shareholders have until
August 5, 2022 to petition the
court. Your ability to share in any recovery doesn't require that
you serve as a lead plaintiff.
According to a filed complaint, Apyx Medical Corporation issued
materially false and/or misleading statements and/or failed to
disclose that: (1) a significant number of Apyx's Advanced Energy
products were used for off-label indications; (2) such off-label
uses led to an increase in the number of medical device reports
filed by Apyx reporting serious adverse events; (3) as a result,
the Company was reasonably likely to incur regulatory scrutiny; (4)
as a result of the foregoing, the Company's financial results would
be adversely impacted; and (5) as a result of the foregoing,
defendants' positive statements about the Company's business,
operations, and prospects were materially misleading and/or lacked
a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for
shareholders who have been the victim of securities fraud. Attorney
advertising. Prior results do not guarantee similar outcomes.
1140 Avenue of the Americas
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE Jakubowitz Law